Patent · US Active

Pyrazole amide derivative

US9365522B2 · kind B2 · utility

2Cited by

1References

14Claims

0Family size

Assignees

AMGEN INC. · US
Teijin Pharma Limited · JP

Inventors

Hilary Plake Beck · Emerald Hills, US
Shon Booker · Thousand Oaks, US
Howard Bregman · Melrose, US
Victor J. Cee · Thousand Oaks, US
Nagasree Chakka · Waltham, US
Timothy D. Cushing · Pacifica, US
Oleg Epstein · Belmont, US
Brian M. Fox · Brisbane, US
Stephanie Geuns-Meyer · Medford, US
Xiaolin Hao · Foster City, US
Kenta Hibiya · Tokyo, JP
Jun Hirata · Tokyo, JP
Zihao Hua · Andover, US
Jason Brooks Human · Boston, US
Shinji Kakuda · Tokyo, JP
Patricia Lopez · Calabasas, US
Ryota Nakajima · Tokyo, JP
Kazuhisa Okada · Tokyo, JP
Steven H. Olson · Millbrae, US
Hiroyuki Oono · Tokyo, JP
Lewis D. Pennington · Ventura, US
Kosuke Sasaki · Tokyo, JP
Keiko Shimada · Tokyo, JP
Youngsook Shin · Emeryville, US
Ryan White · Thousand Oaks, US
Ryan Wurz · Newbury Park, US
Shuyan Yi · Malden, US
Xiao Mei Zheng · Natick, US

Key dates

Filing date	Feb 27, 2015
Grant date	Jun 14, 2016
Priority date	—
Expiry date	Feb 27, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D493/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a novel compound having a function of inhibiting RORγ activity. The present invention also relates to pharmaceutical composition comprising the compound, a use of the compound in treating or preventing autoimmune diseases, inflammatory diseases, metabolic diseases, or cancer diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.